A clinician-focused guide to monitoring children under 12 exposed to AndroGel (testosterone gel): bone age, growth velocity, hormone panels, virilization signs, and safety protocols based on FDA labeling and pediatric endocrinology guidelines.
A guide to AndroGel (testosterone gel) safety in children under 12, covering accidental exposure risks, FDA black-box warnings, secondary virilization, and safe handling protocols.
A guide to how AndroGel (testosterone gel 1% and 1.62%) affects appetite, hunger signaling, and food cravings in men with hypogonadism, with primary-literature citations throughout.
A guide to using AndroGel (testosterone 1% and 1.62% gel) in men with autoimmune conditions, covering immune modulation, drug interactions, monitoring protocols, and clinical trial data.
A clinician-level review of AndroGel (testosterone gel 1% and 1.62%) cardiovascular safety data, including the T-Trials, TRAVERSE, and FDA label updates. Covers MACE risk, hematocrit changes, and monitoring protocols.
A clinical review of AndroGel (testosterone gel 1.62%) effects on memory, processing speed, and cognitive function in hypogonadal men, including T-Trials data, dosing, and monitoring guidance.
A comparison of compounded testosterone gel versus branded AndroGel, covering pharmacokinetics, cost, safety, regulatory status, and how to choose between them.
A week-by-week breakdown of what to expect in your first month on AndroGel (testosterone gel 1% / 1.62%), backed by primary clinical trial data and physician-level dosing guidance.
A clinician-level review of how AndroGel (testosterone gel 1% and 1.62%) affects resting metabolic rate, fat oxidation, lean mass, insulin sensitivity, and overall energy expenditure in men with hypogonadism.
Evidence-based strategies for preserving and building lean mass while using AndroGel (testosterone gel 1% and 1.62%) for male hypogonadism, including dosing, exercise, nutrition, and monitoring protocols.
Topical testosterone gel (AndroGel) after bariatric surgery presents unique pharmacokinetic and clinical challenges. Learn how absorption changes, dosing adjustments, and monitoring protocols differ in post-bariatric patients with hypogonadism.
A guide to AOD-9604 safety in adolescents aged 12, 17, covering the absence of pediatric trial data, growth-plate risks, regulatory status, and when clinicians must decline prescribing.
A detailed safety guide for AOD-9604 (HGH fragment 176-191) in adults aged 30, 49, covering clinical trial evidence, adverse effects, dosing, regulatory status, and what to discuss with your prescriber.
A clinical guide to AOD-9604 (HGH fragment 176-191) monitoring in children under 12, covering safety data gaps, FDA regulatory status, growth surveillance, and recommended laboratory protocols.
A clinical review of AOD-9604 (HGH fragment 176-191) safety and pharmacology in patients with autoimmune conditions, covering IGF-1 axis effects, immune modulation data, prescribing cautions, and monitoring protocols.
A clinician-level review of AOD-9604 (HGH fragment 176-191) and its cancer risk profile, covering preclinical data, IGF-1 pathway biology, regulatory status, and what a prescribing physician needs to know before compounding this peptide.
A clinician-level review of AOD-9604 (HGH fragment 176-191) and its effects on liver function, covering available trial data, proposed mechanisms, hepatic enzyme markers, and what prescribers and patients need to monitor.
A guide to AOD-9604 (HGH fragment 176-191) microdosing protocols, covering the clinical trial data, proposed mechanisms, compounding regulations, and what patients and clinicians need to know before use.
Why AOD-9604 (HGH fragment 176-191) stops working, and exactly what to do about it. Clinician-level analysis of receptor adaptation, dosing variables, compounding quality, and combination strategies, with primary-literature citations.
A clinical guide to AOD-9604 (HGH fragment 176-191) after bariatric surgery, covering mechanism, dosing, safety, and what current evidence does and does not support.
Board-reviewed protocols for timing AOD-9604 (HGH fragment 176-191) doses across time zones, managing circadian disruption, and preserving lipolytic efficacy during travel.
A breakdown of compounded oxandrolone (Anavar) pricing, dosing costs, legal status, and how it compares to SARMs. Includes real dose ranges, pharmacy tiers, and what drives price variation.
A clinical breakdown of SARMs pricing, legal status, compounded anavar costs, and safer prescription alternatives. prepared by the HealthRX.com Editorial Team.
A detailed, evidence-based pricing analysis of 9amHealth's diabetes and GLP-1 telehealth platform, including total out-of-pocket cost, insurance coverage, and how it compares to alternatives.
An independent, evidence-based analysis of Alto Pharmacy's real customer outcomes, adherence data, specialty drug handling, and how it compares to brick-and-mortar and mail-order alternatives.
A data-driven, clinically grounded breakdown of AG1's pricing, ingredient evidence, and whether the $99/month cost holds up against published research and cheaper alternatives.
An independent cost breakdown of Cerebral's mental health and ADHD telehealth plans, including insurance coverage, cash-pay pricing, and how Cerebral compares to in-person and competing telehealth alternatives.
Cost Plus Drugs saves 50-90% on generics but stocks almost no brand-name drugs, no insurance accepted, cash pay only with HSA/FSA cards allowed.
An evidence-based, critically independent analysis of Cost Plus Drugs pricing, legitimacy, real-world savings, and how it compares to GoodRx, Mark Cuban's pharmacy, and traditional insurance for generic medications.
A clinical breakdown of Done's best alternatives for ADHD telehealth, including cost, prescribing practices, stimulant vs. Non-stimulant options, and how to choose the right platform for your situation.
An evidence-based assessment of FuturHealth's safety record, regulatory compliance posture, prescribing practices, and how it compares to alternatives in the GLP-1 telehealth space.
A detailed cost breakdown of Henry Meds GLP-1 compounded weight-loss programs, compared against FDA-approved alternatives and competing telehealth platforms, with cited clinical evidence.
An independent breakdown of Marek Health's pricing for TRT, peptides, and lab optimization. We cover membership fees, lab costs, medication costs, and how the total compares to clinical evidence and alternatives.
A critical, evidence-based review of Pandia Health's telehealth intake and prescription process for birth control and menopause care, including costs, clinical protocols, and comparisons with alternatives.
An evidence-based assessment of Pandia Health's safety record, regulatory standing, prescribing practices, and how it compares to alternatives for birth control and menopause telehealth.
An independent clinical review of Seed Health's DS-01 probiotic: safety record, regulatory status, strain-level evidence, third-party testing claims, and how it compares to alternatives.
An independent clinical assessment of who Strut Health is best suited for, covering men's hair loss, ED, GLP-1, and peptide prescriptions, with evidence-based analysis of costs, legitimacy, and alternatives.
An evidence-based review of Truepill's pharmacy infrastructure, regulatory compliance history, DEA and state board actions, and how it compares to alternative telehealth pharmacy platforms.
A critical, evidence-based review of Allara Health's pricing history, membership fee changes, insurance coverage model, and PCOS care costs from 2020 to 2025.
A critical guide to the patient profiles that make Alloy's direct-to-consumer HRT model a poor fit, including contraindications, safety gaps, and when in-person care is non-negotiable.
An independent look at Alto Pharmacy's LegitScript status, state board licensure, BBB rating, NABP accreditation, and what the evidence means for patients filling specialty or GLP-1 prescriptions.
An independent review of Amazon Pharmacy's LegitScript certification, NABP accreditation, BBB rating, state licensing, and complaint history. Find out whether Amazon Pharmacy is a safe, legitimate place to fill prescriptions.
An independent, evidence-based review of AG1 (Athletic Greens) BBB rating, consumer complaints, ingredient safety, and subscription practices. prepared by the HealthRX.com Editorial Team.
An independent, evidence-based review of AG1 (Athletic Greens) LegitScript status, BBB rating, FDA regulatory standing, and consumer complaint history. prepared by the HealthRX.com Editorial Team.
An independent, evidence-based review of Belmar Pharmacy's LegitScript status, PCAB accreditation, FDA warning history, state board standing, and BBB record for patients considering compounded BHRT or other compounded medications.
An independent, clinically grounded review of BetterHelp's data-privacy record, therapy outcomes signals, prescribing limitations, regulatory complaints, and what verified evidence actually shows about platform legitimacy.
Brightside Health costs $95-$349/month depending on plan. See pricing trends since 2019, insurance coverage details, and BBB billing complaints before you sign up.
An independent review of Calibrate's LegitScript status, state telehealth licensing, BBB complaints, FDA compliance, and clinical transparency. Updated with primary-source citations.
An independent review of Capsule pharmacy's LegitScript status, state licensure, BBB rating, and accreditation record. Find out what the evidence says before you fill your prescriptions there.
A detailed, evidence-grounded look at Capsule pharmacy's pricing history, cost trajectory, insurance compatibility, cash-pay options, and legitimacy, with citations to FDA, BBB, state board, and LegitScript records.
An independent review of Cerebral's Better Business Bureau rating, consumer complaint patterns, DEA investigations, state medical board actions, and what patients should check before enrolling in Cerebral's mental-health or ADHD telehealth service.
An independent, evidence-based review of Cerebral's mental health and ADHD telehealth service, covering which patient profiles are poor fits, verified complaints, regulatory history, and how to choose a safer alternative.
An independent review of Defy Medical's pricing history, fee trajectory, and service model for TRT, peptides, and longevity care, with citations to BBB, FDA, and regulatory sources.
An independent review of Done's LegitScript certification status, BBB complaints, DEA compliance, and state medical board standing for ADHD telehealth prescribing.
An independent review of Elektra Health's LegitScript status, state medical board compliance, BBB rating, and telehealth accreditation for menopause care, with primary source citations.
A data-driven, critical review of Elektra Health's pricing history, membership model changes, legitimacy, and what menopause patients should know before subscribing.
An independent look at Emerge's GLP-1 telehealth pricing history, cost trajectory, complaint record, and legitimacy, with primary-source citations and a clinical framework for evaluating cash-pay GLP-1 platforms.
An independent review of Evernow's medical leadership, clinical credentials, prescribing model, and safety record for perimenopause and menopause hormone therapy.
A critical, data-driven look at Evernow's pricing history, subscription changes, and value trajectory for perimenopause and menopause telehealth care. Includes complaint analysis, legitimacy check, and cost comparisons.
A critical, data-driven look at Function Health's pricing history, membership cost changes, what the subscription covers, and whether the service is worth it compared to direct-lab alternatives.